Targeted MRI/Ultrasound Fusion Biopsy
A more accurate prostate cancer testing technology
MRI technology combined with the standard ultrasound imaging from the trans-rectal ultrasound prostate exam to create a 3D roadmap of the patient’s prostate exposing areas that were previously not visible during traditional ultrasound screening. This thorough diagnostic technology has led to the discovery of early stage tumors improving the patient’s prognosis and treatment options.
The technology combines two systems, the DynaCAD for Prostate and the UroNav fusion biopsy system. This advanced technology fuses pre-biopsy MR images of the prostate with ultrasound guided biopsy images in real time, for excellent visualization and targeting of the possible prostate cancer. It is poised to become the new standard in prostate care.
“Providing the highest level of medical care to our patients has always been our goal. We believe the MRI/ultrasound fusion guided prostate biopsy will reduce the number of false-positive biopsies and result in earlier diagnosis when cancer is present. Now we can more precisely target the biopsy needles exactly where we think the cancer is located. It’s a game-changer,” said Dr. Stephen Taylor.
- A normal Prostate MRI is 90 percent accurate for excluding the presence of prostate cancer. A normal MRI may eliminate the need for a prostate biopsy, avoiding the discomfort and small risk associated with a biopsy.
- Prostate MRI can potentially identify specific areas within the gland that are suspicious and require further evaluation.
- Performing biopsy with MRI/ultrasound fusion guided is more accurate in targeting the suspicious areas, which may have been “hiding” in the prostate.
- Finding cancer early means treatment begins earlier and outcomes are better.
Who is a candidate?
- Patients with elevated Prostate-Specific Antigen (PSA) level 4 or greater.
- Patients with prior negative trans-rectal ultrasound guided biopsy with continued elevation or rising PSA.
- Patients with positive digital rectal examination with negative trans-rectal ultrasound guided biopsy.
Please contact our office to learn more about how Pacific Urology is using the latest in targeted MRI/ultrasound technology in our approach to prostate care.